5 things to watch on the ASX 200 on Wednesday

The ASX 200 looks set to rebound on Wednesday…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) fell heavily after the Reserve Bank increased rates more than expected. The benchmark index fell 1.5% to 7,095.7 points.

Will the market be able to bounce back from this on Wednesday? Here are five things to watch:

Smiling man with phone in wheelchair watching stocks and trends on computer

Image Source: Getty Images

ASX 200 expected to rebound

The Australian share market looks set to rebound on Wednesday following a solid night of trade in the US. According to the latest SPI futures, the ASX 200 is expected to open the day 54 points or 0.75% higher this morning. On Wall Street, the Dow Jones rose 0.8%, the S&P 500 climbed 0.95%, and the Nasdaq was also up 0.95% after bond yields eased.

Platinum update

The Platinum Asset Management Ltd (ASX: PTM) share price will be on watch today following the release of the fund manager's latest funds under management (FUM) update. That update revealed that Platinum experienced net outflows of approximately $209 million In May. This left it with FUM of $19,588 million.

Oil prices rise

Energy producers such as Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) could have a good day after a solid night of trade for oil prices. According to Bloomberg, the WTI crude oil price is up 1.3% to US$120.02 a barrel and the Brent crude oil price has risen 1.3% to US$121.09 a barrel. Concerns over tight supplies continue to keep oil prices at high levels.

ResMed rated as a buy

The ResMed Inc (ASX: RMD) share price could be good value according to analysts at Goldman Sachs. This morning the broker has reiterated its buy rating and $34.40 price target, implying potential upside of ~20%. Goldman notes that there "is a 12-18 month backlog of new patients waiting to be diagnosed."

Gold price climbs

Gold miners Evolution Mining Ltd (ASX: EVN) and Northern Star Resources Ltd (ASX: NST) could have a decent day after the gold price climbed overnight. According to CNBC, the spot gold price is up 0.65% to US$1,855.4 an ounce. The safe haven asset was boosted by falling bond yields.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a shaky, but positive, start to the week's trading.

Read more »

A graphic depicting a businessman in a business suit standing with his hand to his chin looking at a large red arrow pointing upwards above a line up of oil barrels againist the backdrop of a world map.
Energy Shares

With Hormuz closed, is there an opening to buy Woodside shares?

Should investors react to this news out of the Middle East?

Read more »

A group of three men in hard hats and high visibility vests stand together at a mine site while one points and the others look on with piles of dirt and mining equipment in the background.
Broker Notes

How high does Macquarie think Fortescue shares will go?

The broker is positive on the company's outlook.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Broker Notes

Experts name 3 big-name ASX 200 shares to sell

These shares are in the bad books, but for what reason?

Read more »

Two smiling work colleagues discuss an investment at their office.
Broker Notes

Why Mesoblast shares could double in value

This biotechnology company just became less risky according to Bell Potter.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: TechnologyOne, Pro Medicus, PLS Group shares

Here's what John Athanasiou from Red Leaf Securities thinks of these three ASX 200 shares.

Read more »

Miner looking at a tablet.
Broker Notes

Should you buy BHP shares FY27? Here's what experts are saying

Is another powerful rally on the cards for the mining giant?

Read more »

A trio of ASX shares analysts huddle together in an office with computer screens all around them showing share price movements
Broker Notes

Buy, hold, sell: James Hardie, Adairs, Minerals 260 shares

Morgans has updated its ratings on these three ASX shares.

Read more »